Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Wolf

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Schizophrenia (Heidelberg, Germany)|May 21, 2025
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerationsDiana O Perkins, Clark D Jeffries, Scott R Clark, et al.
Molecular Psychiatry|May 5, 2023
Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortiumDominic B Dwyer, Ganesh B Chand, Alessandro Pigoni, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical TrialClara Fonteneau, Zailyn Tamayo, Ally Price, et al.
Schizophrenia Research|May 14, 2020
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefitScott W Woods, Carrie E Bearden, Fred W Sabb, et al.
Aperture Neuro|June 17, 2026
An open, fully-processed data resource for studying mood and sleep variability in the developing brainJuliette B H Brook, Taylor Salo, Audrey C Luo, et al.
Journal of Psychiatric Research|January 10, 2026
A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trialClara Fonteneau, Zailyn Tamayo, Ally Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
Genomic loci influence patterns of structural covariance in the human brainJunhao Wen, Ilya M Nasrallah, Ahmed Abdulkadir, et al.
Schizophrenia (Heidelberg, Germany)|April 3, 2025
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia ProgramNora Penzel, Pablo Polosecki, Jean Addington, et al.
Schizophrenia (Heidelberg, Germany)|April 3, 2025
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia ProgramTashrif Billah, Kang Ik K Cho, Owen Borders, et al.
Molecular Psychiatry|September 2, 2018
Using structural MRI to identify bipolar disorders - 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working GroupAbraham Nunes, Hugo G Schnack, Christopher R K Ching, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Schizophrenia (Heidelberg, Germany)|May 21, 2025
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerationsDiana O Perkins, Clark D Jeffries, Scott R Clark, et al.
Molecular Psychiatry|May 5, 2023
Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortiumDominic B Dwyer, Ganesh B Chand, Alessandro Pigoni, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical TrialClara Fonteneau, Zailyn Tamayo, Ally Price, et al.
Schizophrenia Research|May 14, 2020
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefitScott W Woods, Carrie E Bearden, Fred W Sabb, et al.
Aperture Neuro|June 17, 2026
An open, fully-processed data resource for studying mood and sleep variability in the developing brainJuliette B H Brook, Taylor Salo, Audrey C Luo, et al.
Journal of Psychiatric Research|January 10, 2026
A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trialClara Fonteneau, Zailyn Tamayo, Ally Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
Genomic loci influence patterns of structural covariance in the human brainJunhao Wen, Ilya M Nasrallah, Ahmed Abdulkadir, et al.
Schizophrenia (Heidelberg, Germany)|April 3, 2025
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia ProgramNora Penzel, Pablo Polosecki, Jean Addington, et al.
Schizophrenia (Heidelberg, Germany)|April 3, 2025
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia ProgramTashrif Billah, Kang Ik K Cho, Owen Borders, et al.
Molecular Psychiatry|September 2, 2018
Using structural MRI to identify bipolar disorders - 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working GroupAbraham Nunes, Hugo G Schnack, Christopher R K Ching, et al.
Pageof 15